Valiant Organics Limited (IN:VALIANTORG)
:VALIANTORG
Top Page
Valiant Organics Limited
(VALIANTORG)
Select Model
Select Model
Rating:47Neutral
Price Target:
₹258.00
▼(-7.86% Downside)
Action:ReiteratedDate:03/24/26
The score is held back primarily by weak financial performance (declining revenue, losses, and inconsistent cash flow) and a demanding valuation (high P/E). Technicals are mixed and provide only limited support, with short-term improvement but a still-negative longer-term trend.
Positive Factors
Diversified end-market exposure
Serving agrochemicals, pharmaceuticals, dyes and other specialty segments gives durable demand diversification. Exposure across multiple downstream industries cushions revenue swings from any single end market, supports steady order flow, and underpins long-term commercial resilience.
Negative Factors
Declining revenue trend
A multi-year decline in topline undermines scale economics and long-run competitiveness. Shrinking revenue limits the firm's ability to cover fixed costs, invest in capacity or R&D, and makes returning to sustainable profitability harder without clear new growth engines or market share gains.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified end-market exposure
Serving agrochemicals, pharmaceuticals, dyes and other specialty segments gives durable demand diversification. Exposure across multiple downstream industries cushions revenue swings from any single end market, supports steady order flow, and underpins long-term commercial resilience.
Read all positive factors
Valiant Organics Limited (VALIANTORG) vs. iShares MSCI India ETF (INDA)
Market Cap
₹7.35B
Dividend YieldN/A
Average Volume (3M)2.15K
Price to Earnings (P/E)52.6
Beta (1Y)0.90
Revenue Growth16.43%
EPS GrowthN/A
CountryIN
Employees1,073
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)1.30
Shares Outstanding28,019,610
10 Day Avg. Volume2,085
30 Day Avg. Volume2,152
Financial Highlights & Ratios
PEG Ratio3.90
Price to Book (P/B)1.13
Price to Sales (P/S)1.14
P/FCF Ratio31.87
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Valiant Organics Limited Business Overview & Revenue Model
Company Description
Valiant Organics Limited, a chemical manufacturing company, manufactures and markets specialty chemicals in India. Its products include para chlorophenol; ortho chlorophenol; 2,4 di-chlorophenol; 2,4,6 tri- chlorophenol; 2,6 di-chlorophenol; and p...
How the Company Makes Money
null...
Valiant Organics Limited Financial Statement Overview
Summary
Income Statement
35
Negative
Balance Sheet
60
Neutral
Cash Flow
45
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.52B | 7.19B | 7.23B | 10.52B | 11.53B | 7.55B |
| Gross Profit | 2.67B | 2.62B | 470.01M | 1.81B | 2.17B | 2.19B |
| EBITDA | 895.07M | 615.51M | 425.75M | 1.77B | 2.12B | 2.11B |
| Net Income | 235.33M | -37.36M | -83.91M | 881.21M | 1.13B | 1.15B |
Balance Sheet | ||||||
| Total Assets | 11.63B | 11.83B | 12.48B | 12.39B | 11.92B | 8.76B |
| Cash, Cash Equivalents and Short-Term Investments | 107.93M | 131.53M | 71.02M | 456.71M | 499.47M | 349.85M |
| Total Debt | 2.36B | 2.49B | 2.57B | 2.74B | 3.63B | 2.09B |
| Total Liabilities | 4.23B | 4.58B | 5.19B | 4.99B | 5.43B | 3.68B |
| Stockholders Equity | 7.40B | 7.25B | 7.29B | 6.89B | 6.13B | 5.02B |
Cash Flow | ||||||
| Free Cash Flow | 797.52M | 256.03M | 90.70M | 862.19M | -1.53B | -562.54M |
| Operating Cash Flow | 922.42M | 564.32M | 840.00M | 2.38B | -307.47M | 1.15B |
| Investing Cash Flow | -702.45M | -209.61M | -649.88M | -1.43B | -1.24B | -1.59B |
| Financing Cash Flow | -230.76M | -318.13M | -231.19M | -1.12B | 1.67B | 486.70M |
Valiant Organics Limited Technical Analysis
Positive
280.00
Price Trends
240.15
Positive
252.16
Positive
304.52
Negative
Market Momentum
6.44
Negative
58.85
Neutral
88.79
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VALIANTORG, the sentiment is Positive. The current price of 280 is above the 20-day moving average (MA) of 234.97, above the 50-day MA of 240.15, and below the 200-day MA of 304.52, indicating a neutral trend. The MACD of 6.44 indicates Negative momentum. The RSI at 58.85 is Neutral, neither overbought nor oversold. The STOCH value of 88.79 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:VALIANTORG.
Valiant Organics Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ₹11.74B | 17.06 | ― | ― | 8.45% | -14.27% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | ₹5.28B | -5.44 | ― | 0.50% | -3.11% | -331.77% | |
49 Neutral | ₹7.71B | -10.64 | ― | 0.39% | ― | ― | |
48 Neutral | ₹9.26B | -467.16 | ― | 0.08% | -28.32% | 93.44% | |
47 Neutral | ₹7.35B | 52.56 | ― | ― | 16.43% | ― | |
46 Neutral | ₹6.48B | -2,425.33 | ― | 1.07% | -22.10% | -85.56% |
* Basic Materials Sector Average
IN:VALIANTORG
Valiant Organics Limited
262.35
-90.90
-25.73%
IN:BHARATWIRE
Bharat Wire Ropes Ltd.
171.15
-11.80
-6.45%
IN:DECCANCE
Deccan Cements Ltd
660.80
-101.38
-13.30%
IN:EVERESTIND
Everest Industries Limited
332.95
-135.31
-28.90%
IN:FAIRCHEMOR
Fairchem Organics Ltd
514.55
-363.24
-41.38%
IN:HERANBA
Heranba Industries Limited
192.65
-45.97
-19.26%
Valiant Organics Limited Corporate Events
Valiant Organics Files SEBI Compliance Certificate as All Shares Remain Dematerialized
Apr 4, 2026
Valiant Organics Limited has submitted to the stock exchanges a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter and year ended 31 March 2026. The certificate, issued by it...
Valiant Organics Closes Trading Window Ahead of FY26 Results
Mar 26, 2026
Valiant Organics Limited has announced that its trading window for dealing in the company’s securities will be closed for directors, promoters, promoter group members, designated persons, their immediate relatives, and other connected person...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.